Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients

Bipolar Disorder

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review

doi: 10.1016/j.euroneuro.2019.02.003.

Bipolar Disorder

Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence

Bipolar Disord.

Boyce P, Irwin L, Morris G, Hamilton A, Mulder R, Malhi GS, Porter RJ

doi: 10.1111/bdi.12698.

Psychosis and Schizophrenia

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

JAMA Psychiatry.

Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H

doi: 10.1001/jamapsychiatry.

Psychosis and Schizophrenia

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies

Lancet Psychiatry

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU

doi: 10.1016/S2215-0366(21)00039-0

Psychosis and Schizophrenia

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Lancet Psychiatry.

Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM

doi: 10.1016/S2215-0366(20)30264-9.

Stroke

Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack

CMAJ.

Edwards JD, Kapral MK, Fang J, Swartz RH

doi: 10.1503/cmaj.161142.

Migraine and HeadachePsychosis and Schizophrenia

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Schizophr Res.

Durgam S, Earley W, Li R, Li D, Lu K, Laszlovszky I, Fleischhacker WW, Nasrallah HA

doi: 10.1016/j.schres.2016.06.030.

Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review

Lancet Psychiatry.

Sheehan R, Hassiotis A

doi: 10.1016/

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Neuropsychiatr Dis Treat.

Porfirio MC, Gomes de Almeida JP, Stornelli M, Giovinazzo S, Purper-Ouakil D, Masi G

doi: 10.2147/NDT.S127564.

Related content

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review

Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia